Syngenis joins WA research heavyweights in RNA medicine push

The Sydney Morning Herald - Nov 19, 2026

Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.

Read full article

More News

The Morning Herald

The Morning Herald is a fast news provider in the United States since 2005. Fiercely independent and armed with irreverent intelligence, there’s no other place to get your news other than The Morning Herald.

NEWSLETTER